Budding viral hijackers co-opt the endocytic machinery to make a getaway by Martindale, Diane
Viruses are champions when it comes
to commandeering the normal biolog-
ical processes of their hosts. In the
case of viruses with small genomes,
such as the retroviral human immun-
odeficiency virus (HIV) and influenza,
the limited coding capacity of the viral
genome forces the virus to use many
host cell factors to extend its capabili-
ties during entry into, replication
within, and budding from the cells of
its host. There is currently a lot of
interest in understanding how retro-
viruses interact with their hosts. Work
in this area not only helps us under-
stand how viruses replicate, but also
sheds light on normal cellular
processes.
A great deal of attention has been
given to how viruses latch onto cell-
surface receptors and hijack other com-
ponents to enter and replicate in the
host cells, but much less is known
about how they usurp the cellular
machinery to orchestrate their exodus.
Recently, a new model of virus budding
has come onto the scene. It posits that
enveloped RNA viruses bud by appro-
priating the endocytic cellular machin-
ery that is normally used to create
vesicles inside the cell: the formation of
vesicles and the budding of a virus are
topologically the same process, but
the reverse of each other. This model
has many implications for cell biology
and viral pathogenesis, and virologists
are now busy uncovering how viruses
use the machinery of endocytosis to
their benefit. 
In this issue of Journal of Biology
[1], Margaret Wang, Wankee Kim,
Pietro De Camilli, Stephen Goff and
colleagues bring us a step closer by
describing the identification of a new
endocytic protein involved in the pro-
duction of a retrovirus, the Moloney
murine leukemia virus (Mo-MuLV).
The authors characterize the associa-
tion of a protein involved in the for-
mation of endocytic vesicles,
endophilin 2, with the Mo-MuLV
protein Gag, and a possible role for
this interaction in the production of
virus particles. The study identifies a
potentially significant new player in
retrovirus release and opens up a new
line of investigation aimed at under-
standing the interplay between endo-
cytosis and the cellular release of
retroviral particles (see ‘The bottom
line’ box for a summary of their
work).
All retroviruses have three key genes,
encoding proteins called Gag, Env and
Pol. Gag is the structural protein that
makes up the viral core and drives viral
assembly and release. Gag is a polypro-
tein and is organized into four distinct
regions: the matrix (MA) domain, which
is closely associated with the plasma
membrane and implicated in budding
functions; the capsid (CA), which con-
denses to form ordered core particles
that make up the internal shell of the
virus; the nucleocapsid (NC), an RNA-
binding protein; and a cleavage product
whose name, as well as function, varies
depending on the virus (for example,
for HIV it is called p6 and for Mo-MuLV
it is p12). 
Late in the infection cycle of Mo-
MuLV (see the ‘Background’ box), the
viral Gag polyprotein captures the
RNA genome, binds to the plasma
membrane and assembles into spher-
ical enveloped particles that bud
from the cell. Gag is known as the
particle-making machine because it
can assemble and bud in the absence
of other viral proteins. Hence, any
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A retroviral Gag protein interacts with a cellular protein involved in forming endocytic vesicles in
a manner that affects the production of virus particles. These findings help define the suite of
host-cell components that are usurped by the virus to help it propagate. 
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viral budding and membrane fission
must be supplied by the cell and
recruited by Gag.
Assays in vitro
To identify further which cellular factors
are recruited by Mo-MuLV during the
production and budding of virus parti-
cles, Wang et al. [1] used a yeast two-
hybrid assay of a mouse T-lymphoma
cDNA library using Gag as bait and
identified endophilin 2 as a Gag-
binding partner. A second yeast two-
hybrid screen showed that endophilin 2
interacts specifically with the MA
portion of Gag. In vitro binding assays
further confirmed the endophilin-Gag
association.
Members of the endophilin family
of proteins are involved in endocytic
vesicle formation. Endophilin 2 is one
of three members of the subgroup
endophilin A and is a regulatory com-
ponent of the machinery involved in
clathrin-mediated endocytosis. These
proteins are known to promote
membrane curvature and bending and
are involved in the vesicular trafficking
events of endocytosis [2].
“Many suspected that endophilins
were going to be involved in budding
because of their known function,”
says Stephen Goff (from the Depart-
ment of Microbiology at Columbia
University in New York City, USA, and
senior author of the Journal of Biology
article). “Sometimes, when you do
these screens you recover these pro-
teins that are obscure. When we saw
endophilin, we realized we had one
that made sense.” (See the ‘Behind the
scenes’ box for further discussion of
the motivation for the work.)
Wesley Sundquist, in the Depart-
ment of Biochemistry at the University
of Utah in Salt Lake City, USA, agrees
and is quite excited about Goff’s dis-
covery. “This is of particular interest
because it indicates that proteins that
normally function primarily in the
process of endocytosis or endosomal
trafficking also participate in Mo-
MuLV replication,” he says.
Assays in vivo
Next, Wang et al. [1] set out to deter-
mine whether endophilins were incor-
porated into virus particles. They did
experiments in which viral particles
from cell lysates were harvested using a
sucrose density gradient and proteins
in these virions were detected and ana-
lyzed by western (immuno-) blotting.
They found that both endogenous and
exogenous endophilin 2 (tagged with
the influenza hemagglutinin, HA) is
packaged into Mo-MuLV particles. Addi-
tional tests confirmed that endophilin 2
was indeed present inside the virion
and not simply a contaminant in the
purified virions or attached on the
outer surface of the particle.
To ensure that endophilin 2 is not
merely incorporated into virion parti-
cles because of its proximity to the
plasma membrane, a clever experiment
was carried out whereby western blots
were probed with antibodies specific
for various other endocytic proteins.
The virologists found that along with
endophilin 2, Mo-MuLV particles con-
tained the prevalent cellular proteins
-actin and clathrin, but not dynamin
2, the major endocytic partner of
endophilin. Hence, it appears that the
association of endophilin 2 with Gag
is deliberate and is likely to play a
specific role in virion production. 
Towards viral therapeutics
The question of whether endophilin 2
is actually required for virion produc-
tion remains somewhat hazy. Wang et
al. thought that ‘knocking down’
endophilin 2 levels with a small inter-
fering RNA (siRNA) might cause virus
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The bottom line  
• According to a current model of enveloped RNA virus egress from
cells, the viruses hijack several components of the host endocytic
pathway in order to escape the cell. The retroviral Gag protein is the
key player in the process of virion assembly at the plasma membrane
and is thought to associate with endocytic proteins to promote virion
budding. 
• A yeast two-hybrid protein-protein interaction screen has identified an
endocytic protein, endophilin 2, that interacts with the Gag protein of
Moloney murine leukemia virus (Mo-MuLV). 
• Endophilins are known to promote membrane curvature and bending
and are involved in vesicular trafficking events of endocytosis. 
• Endophilin 2 is packaged inside the virion and associates with the
matrix portion of Gag.
• Perturbation of endophilin levels affects virion production. Thus, it
seems likely that endophilins are also involved in the budding of Mo-
MuLV. 
• This study increases our understanding of how the endosomal sorting
machinery is linked to retrovirus release and will stimulate further
investigations aimed at more fully defining the cellular components
involved in virus budding.production to go down. Despite reduc-
ing the levels of endophilin 2 by up to
50%, they saw no effect on virion
numbers - but the method could not
fully eliminate endophilin 2, so the
residual protein might have been suffi-
cient for function. In a second attempt
at eliminating the wild-type function
of endophilin 2, dominant-negative
effectors (produced by overexpressing
wild-type or fragmented endophilin 2)
were used to block the protein’s func-
tion, and this did significantly reduce
virion production, although it was not
eliminated entirely. 
These experiments provide evi-
dence that the Gag-endophilin 2 inter-
action is of functional importance,
since viral particle production was
inhibited, says Sundquist. “But there is
the outstanding question that is raised
but not answered by Goff’s work
which is why the virus interacts with
endophilins. So, we now need to
understand why this interaction takes
place, and such experiments can be
very challenging,” he says. 
Heinrich Göttlinger, in the Depart-
ment of Cancer, Immunology and
AIDS at the Dana-Farber Cancer Insti-
tute in Boston, USA, adds that
“although the work is suggestive, Wang
et al. have not yet formally demon-
strated that endophilins are indeed
required for efficient virus release.
Future siRNA knock-downs targeting
all the endophilins simultaneously
should definitively resolve this issue.”
But Goff says that such an experi-
ment is nearly impossible since it
would almost certainly be detrimental
to the cells’ survival. Despite the nega-
tive results with the knockdown experi-
ment, Goff is not discouraged. “This
[negative result] is probably due to
redundancy, where other members of
the endophilin family compensate for
the loss of endophilin 2 expression, or
because the remaining levels of
endophilin 2 inside the cells are abun-
dant enough to carry out their func-
tion.” Indeed, the levels of endophilin 2
needed are likely to be very low, as only
a minute amount of the intracellular
protein is incorporated into virions [1].
“It would also be interesting to know
whether the reduced levels of virus
production induced by endophilin over-
expression are due to a block in virus
release or whether the effect might
be elicited earlier in the virus assem-
bly/release pathway,” says Eric Freed,
Chief of the Virus-Cell Interaction
Section at the National Cancer Insti-
tute in Frederick, USA. 
Interestingly, Wang et al. found
that the Gag-endophilin association
was not conserved among other
retroviruses. Using the yeast two-
hybrid assay, they tested Gag proteins
from HIV, Rous sarcoma virus (RSV),
Mason-Pfizer monkey virus (MPMV)
and simian immunodeficiency virus
(SIV). Endophilin 2 interacted with
Gag from RSV, which is closely
related to Mo-MuLV, but not with
any of the other Gags from more dis-
tantly related viruses. According to
Goff, endophilin could nevertheless
be involved in HIV production,
although indirectly. The alternative is
that some other protein performs the
equivalent function for HIV. “This is
entirely possible. But we do not know
what that protein or proteins might
be,” he adds.
Although it is not yet fully clear
how endophilin 2 helps the virus func-
tion, the authors do speculate that
perhaps endophilin, which normally
helps to generate membrane curvature,
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Background
•  Moloney murine leukemia virus, Mo-MuLV, is a prototypical
enveloped RNA retrovirus and causes tumors in mice. It has been
studied for 40 years and much of what is known about Mo-MuLV is
relevant to other retroviruses, such as HIV. 
•  The yeast two-hybrid assay is a method for detecting an interaction
between any two proteins. The two candidates are each expressed in
yeast as protein fusions: one, the ‘bait’, as a fusion to a DNA-binding
domain and the other, the ‘prey’, as a fusion to a transcriptional
activation domain. The binding of the two proteins of interest, if it
happens, links the DNA-binding domain to the activation domain,
recreating an intact transcriptional activator and resulting in
transcriptional activation of a reporter gene whose promoter contains
the binding site for the DNA-binding domain. 
•  A  sucrose density gradient is a simple method to separate
molecules based on buoyant density or size. Virions have a relatively
unusual density and so are readily resolved from most other cellular
components. 
•  Small interfering RNAs (siRNAs) allow for the specific turning
down or ‘knock-down’ of any gene of interest and a study of the
consequences. The procedure uses short double-stranded (ds) RNAs
(of 20-22 base-pairs) to direct the specific degradation of the
corresponding mRNA, and thereby shuts off the cognate gene. It is
possible either to introduce the dsRNA into cells directly or to
induce the endogenous synthesis of the dsRNA from a hairpin DNA
encoding it. could be helping the virus to distort the
membrane during the process of virion
budding. It might also be that the
endocytic proteins play an important
role in Gag localization and trafficking,
as there are now several indications
that viral Gag proteins are trafficked
via endosomal pathways [3].
Despite the need for more work to
clarify some details, Goff’s findings do
fit nicely with the general idea that is
developing in the field that retro-
viruses make extensive use of the endo-
somal machinery to bud from cells
[4-6]. For example, the very late stages
of HIV-1 release appear to be primarily
promoted by a direct interaction
between the p6 domain of its Gag and
the cellular protein Tsg101, which then
connects Gag with the endosomal
sorting machinery that is involved in
inward budding of vesicles into the
multivesicular body (reviewed in [7]). 
What’s more, many other proteins
that are part of endocytic complexes,
such as Vps28, Hrs, AIP-1, Vps4, and a
group of proteins called CHMPs, have
been shown to associate with Gag via
small motifs called L domains, and are
required for various very late steps in
virion budding and release [7]. Others
have recently shown that infectious
HIV particles can bud internally into
late endosomal compartments in
macrophages [8], and that MuLV RNAs
(and apparently also Gag proteins) are
transported to the cell membrane by
endosomal vesicles [3].
“I think that there is a general feeling
in the field that all of these observations
will ultimately be unified to explain
how retroviruses are trafficked along the
endosomal system and ultimately
released from cells,” says Sundquist.
“Another important aspect of Goff’s
work is that although it has been clear
that retroviruses utilize cellular proteins
that function late in the endosomal
pathway (for example, Tsg101, AIP1,
and Vps4), it has been much less clear
that they utilize proteins that function
earlier in endocytosis, such as
endophilin 2 and clathrin,” he adds. 
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Behind the scenes
Journal of Biology asked Stephen Goff to comment on the background to
the project to search for new host proteins that interact with the
Moloney murine leukemia retrovirus. 
What motivated you to look for host cellular proteins that
interact with Mo-MuLV?
We think there are a large number of host cellular proteins that are yet to
be appreciated as important for retrovirus replication. Some of these, like
endophilin, will likely be involved in one or more of the many steps of
virion assembly. Different retroviruses, and viruses of other families, will
probably use different subsets of these proteins. There will also probably
be even more proteins involved at other stages of the life cycle: viral entry,
uncoating, reverse transcription, entry into the nucleus, proviral formation
and viral gene expression. Discovering these host factors will not only lead
to new antivirals, but also to a greater understanding of cell biology. 
How long did it take your group to do the experiments and what
were the steps that ensured success?
This project has a long history. It actually started eight years ago when
Sandy Morse at the NIH did a large-scale screen for cellular proteins that
interacted with the Gag protein of a murine leukemia virus. We were
doing similar screens with Moloney, but it wasn’t until early 2000 when
Margaret Wang, a new graduate student, decided to look over Sandy’s hits
again. Margaret discovered that one of his initially unknown genes,
recovered many times, was by then identified as endophilin 2. The function
of the endophilins made this gene immediately exciting as it could be
involved in virus assembly, so she decided to work these hits up. The work
described in the paper constituted the major effort of her graduate studies.
What was your initial reaction to the results and how were they
received by others?
We were excited instantly upon the realization that these hits were an
endophilin. It made perfect sense. I remember a conversation with Eric
Freed about the general factors that would be exciting to find as involved
with virion budding, and he proposed that finding a role for endophilins
would be an obvious expectation even before our findings were known.
Given the strong evidence that has come out recently that so many host
proteins are involved in virion budding and release, I think most people in
the field are happy to include them in the list of players.
What are the next steps?
There will be some easy work to survey the viruses that are utilizing this
machinery, and to survey which factors are needed by each virus. There
will be some mapping of the binding between the viral and host proteins.
There may be structural studies, including co-crystallization. The next
difficult issue for all the proteins recently identified as cofactors is to
determine their actual functions in the process. This might involve in vitro
virion assembly reactions, with the inclusion of membranes in these
reactions. But it is also likely to require a more detailed understanding of
membrane biochemistry and behavior.This new model of virus budding
has many implications for both viral
pathogenesis and cell biology. Virus
budding is an attractive new drug
target, because the pathway appears to
be essential and common to many
viruses - although common targets can
also have potential problems arising
from their generality. Cellular targets
might also be less susceptible to drug
resistance than is the case for many
conventional viral targets. “It may be
possible to inhibit retrovirus release by
targeting the lipid-modifying activity
of endophilins with small molecule
inhibitors,” suggests Göttlinger.
Apart from helping design new
antiviral drugs, these studies on viral
budding will certainly extend our
understanding of the endosomal sorting
machinery. In many cases, viruses have
helped in the discovery of fundamental
aspects of cellular biology and facili-
tated their analysis. For instance, onco-
genes were first identified as host
sequences acquired by transforming
retroviruses; reverse transcriptase was
first identified as a viral enzyme; regula-
tion of translation was first seen in the
interferon response to virus infection;
and such processes as inhibition of
translation and use of internal ribosome
entry sites were first studied with
poliovirus. Learning how Mo-MuLV and
other retroviruses use the endocytic
pathway is sure to lead to more new and
exciting discoveries for cell biologists. 
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